Literature DB >> 31068426

K63-Linked Ubiquitin Is Required for Restriction of HIV-1 Reverse Transcription and Capsid Destabilization by Rhesus TRIM5α.

Sabrina Imam1, Sevnur Kömürlü1, Jessica Mattick1, Anastasia Selyutina2, Sarah Talley3, Amani Eddins1, Felipe Diaz-Griffero2, Edward M Campbell4,3.   

Abstract

TRIM5α is an antiviral restriction factor that inhibits retroviral infection in a species-specific fashion. TRIM5α binds to and forms assemblies around the retroviral capsid. Following binding, poorly understood, ubiquitin-dependent events lead to the disassembly of the viral core, prior to the accumulation of viral reverse transcription products in the target cell. It is also known that assemblies of TRIM5α and other TRIM family proteins can be targets of autophagic degradation. The goal of this study was to define the role of specific ubiquitin linkages in the retroviral restriction and autophagic degradation of TRIM5α and delineate any connection between these two processes. To this end, we generated fusion proteins in which the catalytic domains of different deubiquitinase (DUB) enzymes, with different specificities for polyubiquitinated linkages, were fused to the N-terminal RING domain of Rhesus macaque TRIM5α. We assessed the role of ubiquitination in restriction and the degree to which specific types of ubiquitination are required for the association of TRIM5α with autophagic proteins. We determined that K63-linked ubiquitination by TRIM5α is required to induce capsid disassembly and to inhibit reverse transcription of HIV, while the ability to inhibit HIV-1 infection was not dependent on K63-linked ubiquitination. We also observed that K63-linked ubiquitination is required for the association of TRIM5α with autophagosomal membranes and the autophagic adapter protein p62.IMPORTANCE Although the mechanisms by which TRIM5α can induce the abortive disassembly of retroviral capsids have remained obscure, numerous studies have suggested a role for ubiquitination and cellular degradative pathways. These studies have typically relied on global perturbation of cellular degradative pathways. Here, through the use of linkage-specific deubiquitinating enzymes tethered to TRIM5α, we delineate the ubiquitin linkages which drive specific steps in restriction and degradation by TRIM5α, providing evidence for a noncanonical role for K63-linked ubiquitin in the process of retroviral restriction by TRIM5α and potentially providing insight into the mechanism of action of other TRIM family proteins.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  HIV-1; TRIM5alpha; deubiquitinating enzymes; retroviral restriction; ubiquitination

Mesh:

Substances:

Year:  2019        PMID: 31068426      PMCID: PMC6600202          DOI: 10.1128/JVI.00558-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.

Authors:  D Finzi; J Blankson; J D Siliciano; J B Margolick; K Chadwick; T Pierson; K Smith; J Lisziewicz; F Lori; C Flexner; T C Quinn; R E Chaisson; E Rosenberg; B Walker; S Gange; J Gallant; R F Siliciano
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

2.  Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins.

Authors:  Jenny L Anderson; Edward M Campbell; Xiaolu Wu; Nick Vandegraaff; Alan Engelman; Thomas J Hope
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

3.  Characterization of TRIM5alpha trimerization and its contribution to human immunodeficiency virus capsid binding.

Authors:  Hassan Javanbakht; Wen Yuan; Darwin F Yeung; Byeongwoon Song; Felipe Diaz-Griffero; Yuan Li; Xing Li; Matthew Stremlau; Joseph Sodroski
Journal:  Virology       Date:  2006-06-30       Impact factor: 3.616

4.  Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor.

Authors:  Matthew Stremlau; Michel Perron; Mark Lee; Yuan Li; Byeongwoon Song; Hassan Javanbakht; Felipe Diaz-Griffero; Donovan J Anderson; Wesley I Sundquist; Joseph Sodroski
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-15       Impact factor: 11.205

5.  Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection.

Authors:  Xiaolu Wu; Jenny L Anderson; Edward M Campbell; Ajith M Joseph; Thomas J Hope
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-28       Impact factor: 11.205

6.  Requirements for capsid-binding and an effector function in TRIMCyp-mediated restriction of HIV-1.

Authors:  Felipe Diaz-Griffero; Nick Vandegraaff; Yuan Li; Kathleen McGee-Estrada; Matthew Stremlau; Sohanya Welikala; Zhihai Si; Alan Engelman; Joseph Sodroski
Journal:  Virology       Date:  2006-05-02       Impact factor: 3.616

7.  Disruption of the actin cytoskeleton can complement the ability of Nef to enhance human immunodeficiency virus type 1 infectivity.

Authors:  Edward M Campbell; Rafael Nunez; Thomas J Hope
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

8.  p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy.

Authors:  Serhiy Pankiv; Terje Høyvarde Clausen; Trond Lamark; Andreas Brech; Jack-Ansgar Bruun; Heidi Outzen; Aud Øvervatn; Geir Bjørkøy; Terje Johansen
Journal:  J Biol Chem       Date:  2007-06-19       Impact factor: 5.157

9.  The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.

Authors:  Matthew Stremlau; Christopher M Owens; Michel J Perron; Michael Kiessling; Patrick Autissier; Joseph Sodroski
Journal:  Nature       Date:  2004-02-26       Impact factor: 49.962

10.  Visualization of a proteasome-independent intermediate during restriction of HIV-1 by rhesus TRIM5alpha.

Authors:  Edward M Campbell; Omar Perez; Jenny L Anderson; Thomas J Hope
Journal:  J Cell Biol       Date:  2008-02-04       Impact factor: 10.539

View more
  5 in total

1.  Knockdown of TRIM5α or TRIM11 increases lentiviral vector transduction efficiency of human Muller cells.

Authors:  Monica M Sauter; Curtis R Brandt
Journal:  Exp Eye Res       Date:  2021-01-10       Impact factor: 3.467

Review 2.  Visualizing HIV-1 Capsid and Its Interactions with Antivirals and Host Factors.

Authors:  Morganne Wilbourne; Peijun Zhang
Journal:  Viruses       Date:  2021-02-04       Impact factor: 5.818

Review 3.  Regulation of Viral Restriction by Post-Translational Modifications.

Authors:  Célia Chamontin; Guillaume Bossis; Sébastien Nisole; Nathalie J Arhel; Ghizlane Maarifi
Journal:  Viruses       Date:  2021-11-01       Impact factor: 5.048

Review 4.  Is the HTLV-1 Retrovirus Targeted by Host Restriction Factors?

Authors:  Auriane Carcone; Chloé Journo; Hélène Dutartre
Journal:  Viruses       Date:  2022-07-23       Impact factor: 5.818

Review 5.  Emerging Roles of Non-proteolytic Ubiquitination in Tumorigenesis.

Authors:  Xiu Yin; Qingbin Liu; Fen Liu; Xinchen Tian; Tinghao Yan; Jie Han; Shulong Jiang
Journal:  Front Cell Dev Biol       Date:  2022-07-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.